Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial. (Q52672810)

5 May 2018

title

Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial. (English)

1 reference

5 May 2018

main subject

pulmonary tuberculosis

1 reference

32

Soumya Swaminathan

1 reference

5 May 2018

Narendran Gopalan

1

1 reference

5 May 2018

Ramesh Kumar Santhanakrishnan

2

1 reference

5 May 2018

Alangudi Natarajan Palaniappan

3

1 reference

5 May 2018

Pradeep Aravindan Menon

4

1 reference

5 May 2018

Sekar Lakshman

5

1 reference

5 May 2018

Padmapriyadarsini Chandrasekaran

6

1 reference

5 May 2018

Gomathi Narayan Sivaramakrishnan

7

1 reference

5 May 2018

Devarajulu Reddy

8

1 reference

5 May 2018

Bhavani Perumal Kannabiran

9

1 reference

5 May 2018

Hemanth Kumar Kupparam Agiboth

10

1 reference

5 May 2018

Vijay Krishnamoorthy

11

1 reference

5 May 2018

Sridhar Rathinam

12

1 reference

5 May 2018

Chandrasekar Chockalingam

13

1 reference

5 May 2018

Tamizhselvan Manoharan

14

1 reference

5 May 2018

MahilMaran Ayyamperumal

15

1 reference

5 May 2018

Nalini Jayanthi

16

1 reference

5 May 2018

Kumar Satagopan

17

1 reference

5 May 2018

Ravichandran Narayanan

18

1 reference

5 May 2018

Raja Krishnaraja

19

1 reference

5 May 2018

Sekar Sathiyavelu

20

1 reference

5 May 2018

Bhanu Kesavamurthy

21

1 reference

5 May 2018

Chandra Suresh

22

1 reference

5 May 2018

Murugesan Selvachitiram

23

1 reference

5 May 2018

Gunasundari Arasan

24

1 reference

5 May 2018

Stella Susaimuthu

25

1 reference

5 May 2018

Prabhakaran Rathinam

26

1 reference

5 May 2018

Prabhakar Angamuthu

27

1 reference

5 May 2018

Lavanya Jayabal

28

1 reference

5 May 2018

Lakshmi Murali

29

1 reference

5 May 2018

Ranjani Ramachandran

30

1 reference

5 May 2018

Srikanth Prasad Tripathy

31

1 reference

5 May 2018

publication date

5 March 2018

1 reference

5 May 2018

published in

JAMA Internal Medicine

1 reference

5 May 2018

volume

178

1 reference

5 May 2018

page(s)

485-493

1 reference

5 May 2018

issue

4

1 reference

5 May 2018

Intermittent Versus Daily Pulmonary Tuberculosis Treatment Regimens: A Meta-Analysis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Directly-observed intermittent therapy versus unsupervised daily regimen during the intensive phase of antituberculosis therapy in HIV infected patients

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Tuberculosis-immune reconstitution inflammatory syndrome in HIV: from pathogenesis to prediction

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Comparing the Daily Versus the Intermittent Regimens of the Anti-Tubercular Chemotherapy in the Initial Intensive Phase in Non-HIV, Sputum Positive, Pulmonary Tuberculosis Patients

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

A comparison between two strategies for monitoring hepatic function during antituberculous therapy

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Treatment outcomes of patients with HIV and tuberculosis.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885164

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium

2 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29507938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29507938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/JAMAINTERNMED.2018.0141

1 reference

5 May 2018

0 references

1 reference

5 May 2018